|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/48 | (2006.01) |
| A61K 47/02 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 31/405 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 8/19 | (2006.01) | ||
| A61K 8/39 | (2006.01) | ||
| A61K 8/49 | (2006.01) | ||
| A61K 8/66 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61Q 19/08 | (2006.01) | ||
| A61P 5/00 | (2006.01) | ||
| A61P 13/00 | (2006.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 19/02 | (2006.01) |
| (11) | Number of the document | 3463432 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17728095.5 |
| Date of filing the European patent application | 2017-05-26 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation | 2021-01-25 |
| (86) | Number | PCT/EP2017/062785 |
| Date | 2017-05-26 |
| (87) | Number | WO 2017/203038 |
| Date | 2017-11-30 |
| (30) | Number | Date | Country code |
| PCT/EP2016/0620 | 2016-05-27 | WO |
| (72) |
JARSTAD, Anders, SE
FRIIS, Anna, SE
STAHL, Ulf, SE
GURELL, Ann, SE
AGREN, Barbro, SE
EDSTROM, Emilia, SE
PICKETT, Andrew, SE
|
| (73) |
Ipsen Biopharm Limited,
Unit 9, Ash Road Wrexham Industrial Estate, Wrexham LL13 9UF,
GB
Galderma Holding SA , Zählerweg 10, 6300 Zug, CH |
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Skysta neurotoksino kompozicija, stabilizuota triptofanu arba tirozinu |
| LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE |
| Payment date | Validity (years) | Amount | |
| 2025-05-12 | 9 | 208.00 EUR |
| 2026-05-26 |